3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
58
Terminated
14
Withdrawn
5
Unknown
5
Recruiting
3
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
50
Sarcoma
21
Genitourinary
12
Gastrointestinal
12
Lymphoid
10
Myeloid
9
Dermatologic
5
Endocrine
4
Other solid neoplasm
2
Head & Neck
2
Breast
2
Thoracic
1
Other hematologic neoplasm
1
NET
1
Conditions
Leukemia, Myeloid, Acute
208
Leukemia, Lymphocytic, Chronic, B-Cell
136
Precursor Cell Lymphoblastic Leukemia-Lymphoma
132
Hematologic Neoplasms
113
Myelodysplastic Syndromes
96
Leukemia
82
Lymphoma
65
Lymphoma, Non-Hodgkin
57
Multiple Myeloma
43
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
37
Leukemia, Myelomonocytic, Chronic
35
Neoplasms
31
Recurrence
27
Myeloproliferative Disorders
27
Burkitt Lymphoma
25
Lymphoma, Mantle-Cell
23
Leukemia, Biphenotypic, Acute
23
Lymphoma, Large B-Cell, Diffuse
22
Lymphoma, Follicular
20
Lymphoma, B-Cell, Marginal Zone
20
Lymphoma, B-Cell
20
Leukemia, Myeloid, Chronic-Phase
16
Leukemia, B-Cell
16
Hodgkin Disease
16
Primary Myelofibrosis
15
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
15
Waldenstrom Macroglobulinemia
14
Hematologic Diseases
14
Anemia, Refractory, with Excess of Blasts
11
Neoplasm, Residual
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Neuroblastoma
×
Other hematologic neoplasm
×
Clear all
NCT03496402
2025-03-18
MICCHADO
Institut Curie
Phase NA
Active not recruiting
600 enrolled